Negative-pressure wound therapy for III/IV pressure injuries: A meta-analysis.
Yi-Ping SongLei WangBao-Fang YuanHong-Wu ShenLin DuJi-Yu CaiHong-Lin ChenPublished in: Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society (2020)
This meta-analysis was conducted to identify the potential benefits and the efficacy of negative-pressure wound therapy (NPWT) for III/IV pressure injuries (PIs) compared with standard wound care (SWC). Sixteen RCTs with 629 patients were included in our analysis. The methodological quality was assessed by the Cochrane Collaboration Tool. The outcomes included complete ulcer healing rate, wound healing time, pain score, the frequency of dressing change, hospitalization cost, the condition of the exudate, and the wound improvement. The percentage of healing rate was 61.45% for the NPWT group and 36.90% for SWC (95% CI: 1.32-1.70). There were significant differences in wound healing time (WMD = -16.47 days, 95% [CI (-22.36, - 10.59) days, P ≤ .001]). The pain score and hospitalization cost in NPWT was lower compared with SWC group (WMD = -2.39, 95% CI [-3.47, -1.30], P ≤ .001); (SMD = -2.55, 95% CI [-4.07, -1.03], P < .01). The frequency of dressing change in both NPWT groups was greatly reduced (SMD = -3.61, 95% [CI (-4.57, - 2.66) times, P ≤ .001]). Our meta-analysis indicated that NPWT was associated with greater improvements in improving PIs and shorting healing time for III/IV PIs. However, this conclusion needs to be confirmed by high-quality multicenter RCTs.
Keyphrases
- wound healing
- systematic review
- chronic pain
- pain management
- end stage renal disease
- meta analyses
- healthcare
- neuropathic pain
- ejection fraction
- newly diagnosed
- palliative care
- quality improvement
- prognostic factors
- chronic kidney disease
- peritoneal dialysis
- case control
- surgical site infection
- metabolic syndrome
- randomized controlled trial
- mesenchymal stem cells
- cross sectional
- climate change
- spinal cord injury
- adipose tissue
- risk assessment
- bone marrow
- double blind
- weight loss